Coordinated Services and Access to Research for Women, Infants, Children, and Youth
Program Funding
Annual program obligations reported to SAM.gov.
Who has received this funding
Organizations awarded under CFDA 93.153 (USAspending.gov).
- Health, New Jersey Department Of $14,728,052
- University Of Miami $13,294,178
- Montefiore Medical Center $12,244,561
- University Of South Florida $9,821,056
- Washington University, The $8,982,320
- Michigan Department Of Health And Human Services $8,739,148
- University Of California, San Diego $8,727,818
- No Aids Task Force $8,214,274
- Childrens Diagnostic & Treatment Center, Inc. $7,863,724
- The University Of Texas Southwestern Medical Center $7,659,335
Funded Projects
Examples of what this program has supported.
•Nearly 602,000 people with HIV in the U.S. received life-saving care, medication, and essential support services through the Ryan White HIV/AIDS Program, representing over half of those with diagnosed HIV in the U.S. This is an increase of nearly 26,000 clients.
•More than 91% of Ryan White HIV/AIDS Program patients receiving HIV medical care were virally suppressed in 2024. This is up from 69.5% of patients virally suppressed in 2010 and significantly higher than the 67.2% virally suppressed nationally among all people with diagnosed HIV.
•More than 47% of Ryan White HIV/AIDS Program clients are aged 50 years and older, demonstrating the program’s success in supporting older clients.
Program Objective
Part D (base): The purpose of this program is to fund family-centered HIV care and support services in outpatient or ambulatory settings to low-income women, infants, children and youth with HIV, and their affected family members.
Part D (supplemental): The purpose of this one-year supplemental funding is to strengthen organizational infrastructure and increase capacity to develop, enhance, or expand access to high quality family-centered care services. These services are for low-income women, infants, children, and youth (WICY) with HIV in the service area.
Eligibility
Eligible Applicants
- U.S. State Government
- U.S. Territory Government
- Nonprofit Organization
- Federally Recognized Tribal Government
Eligible applicants are: State (includes District of Columbia, public institutions of higher education and hospitals), Local (includes State-designated Indian Tribes, excludes institutions of higher education and hospitals, Public nonprofit institution/organization (includes institutions of higher education and hospitals), Federally Recognized Indian Tribal Governments, U.S. Territories and possessions, Private nonprofit institution/organization (includes institutions of higher education and hospitals), State
Public and nonprofit private entities (including a health facility operated by or pursuant to a contract with the Indian Health Service) that provide family-centered care involving outpatient or ambulatory care (directly or through contracts or memoranda of understanding (MOUs) for WICY with HIV/AIDS.
Beneficiaries
- U.S. State Government
- Nonprofit Organization
- U.S. Territory Government
- Federally Recognized Tribal Government
Specialized group (e.g. health professionals, students, veterans) Women, infants, children, and youth living with HIV and their affected family members.
How to Apply
Award Procedure
Based on the recommendations of the objective review committee, the HRSA program official with delegated authority is responsible for final selection and funding decisions. Notification is made in writing by a Notice of Award (NOA).
Decision Timeline
- Approval: From 120 to 180 days
Approximately 6 months.
Program details & compliance
Description
Part D (base): The purpose of this program is to fund family-centered HIV care and support services in outpatient or ambulatory settings to low-income women, infants, children and youth with HIV, and their affected family members.
Part D (supplemental): The purpose of this one-year supplemental funding is to strengthen organizational infrastructure and increase capacity to develop, enhance, or expand access to high quality family-centered care services. These services are for low-income women, infants, children, and youth (WICY) with HIV in the service area.
Mission Categories
Primary: General Health and Medical
Use of Funds
Allowed Uses
All funds must be expended solely for carrying out the approved project in accordance with the NOFO, the terms and conditions of the award, and the applicable cost principles. No more than 10 percent of total grant funds may be used for administrative costs. All indirect costs count toward this 10% limit. Funds may not be used for purchase, construction, or major alterations or renovations on any building or other facility; purchase or improvement of land; payments for clinical research; payments for nursing home care; cash payments to intended recipients of RWHAP services; research; foreign travel; to directly provide housing or health care services (e.g., HIV care, counseling and testing) that duplicate existing services; or for any item or service to the extent that payment has been made, or reasonably can be expected to be made, with respect to that item or service under any State compensation program, insurance policy, Federal or State health benefits program or by an entity that provides health services on a prepaid basis (except for a program administered by or providing the services of the Indian Health Services). Funds may also not be used towards PrEP or nPEP medications or medical services. As outlined in the June 22, 2016 RWHAP and PrEP program letter, the RWHAP legislation provides grant funds to be used for the care and treatment of people with HIV, thus prohibiting the use of RWHAP funds for PrEP medications or related medical services, such as physician visits and laboratory costs. However, RWHAP Part D funds can be used toward Psychosocial Support Services, a component of family-centered care, which may include counseling and testing and information on PrEP to eligible clients’ partners and affected family members, within the context of a comprehensive PrEP program. Additionally, the purchase of sterile needles or syringes for the purposes of hypodermic injection of any illegal drug is not allowable. Some aspects of Syringe Services Programs are allowable with HRSA's prior approval and in compliance with HHS and HRSA policy (see: https://www.aids.gov/federal-resources/policies/syringe-services-programs/).
Required Documentation
Applicants should review the individual HRSA Notice of Funding Opportunity (NOFO) issued under this Assistance Listing for any required proof or certifications which must be submitted prior to or simultaneous with submission of an application package. All HRSA awards are subject to the Uniform Administrative Requirements, Cost Principles, and Audit Requirements at 2 CFR 200 and modifications at 2 CFR 300. Subpart E - Cost Principles applies to this program.
Reporting & Compliance
Applicable 2 CFR 200 Subparts
- Subpart B — General Provisions
- Subpart C — Pre-Federal Award Requirements
- Subpart D — Post-Federal Award Requirements
- Subpart E — Cost Principles
- Subpart F — Audit Requirements